Exploring DurAVR™ THV EFS data: Pioneering Insights from Expert Physicians at PCR London Valves 2023 Скачать
Exclusive Interview: First Successful Implantation of DurAVR™ THV in a Valve-in-Valve Procedure Скачать
Impressive DurAVR™ THV Patient Data Revealed at 2023 TVT Conference | Anteris Technologies Interview Скачать
Breaking News: Anteris Technologies Shows Promising Results in Human Heart Valve Trial After 30 Days Скачать
Anteris Technologies' DurAVR™ Technology, 'Human-Like Characteristics' has the Medical World Talking Скачать
